News Snapshot:
(Bloomberg) -- Makers of vaccines and other coronavirus treatments dropped in Asia after Merck & Co. said its experimental pill cuts the risk of hospitalization and death from Covid-19 in half. .The declines followed a slump in shares of BioNTech SE and Moderna Inc. in New York on Friday after Merck delivered the news on its drug, which is seen by some as marking a turning point in the global fight against Covid-19..Shanghai Fosun Pharmaceutical Group Co., which has a deal to distribute BioNTech and Pfizer Inc.’s vaccine in Greater China, slumped as much as 21% in Hong Kong, leading...
